Personal information

Countries

Japan

Activities

Collapse all

Employment (2)

The UNIVERSITY of TEXAS,MDAnderso: Houston, TEXAS, US

2019-12-31 to present | postdoctoral fellow (Luekemia-research)
Employment
Source: Self-asserted source
Hidetaka Uryu

National Research Institute for Child Health and Development: Setagaya-ku, Tokyo, JP

2016-12-05 to present | Researcher ( Department of Maternal-Fetal Biology)
Employment
Source: Self-asserted source
Hidetaka Uryu

Education and qualifications (1)

Kyushu University: Fukuoka, Fukuoka, JP

1996-04-01 to 2002-03-31 | B.M. (Medicine)
Education
Source: Self-asserted source
Hidetaka Uryu

Works (25)

Data from A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies

2024-09-16 | Preprint
DOI: 10.1158/2643-3230.c.6692454
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Protocol from A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies

2024-09-16 | Preprint
DOI: 10.1158/2643-3230.27024932.v1
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Protocol from A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies

2024-09-16 | Preprint
DOI: 10.1158/2643-3230.27024932
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Tables and Figures from A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies

2024-09-16 | Preprint
DOI: 10.1158/2643-3230.27024929
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Tables and Figures from A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies

2024-09-16 | Preprint
DOI: 10.1158/2643-3230.27024929.v1
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity

Leukemia
2024-07 | Journal article
DOI: 10.1038/s41375-024-02211-z
Contributors: Matthew Schwede; Katharina Jahn; Jack Kuipers; Linde A. Miles; Robert L. Bowman; Troy Robinson; Ken Furudate; Hidetaka Uryu; Tomoyuki Tanaka; Yuya Sasaki et al.
Source: check_circle
Crossref

SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells

eLife
2024-06-18 | Journal article
DOI: 10.7554/eLife.91611
Contributors: Linda Zhang; Joanne I Hsu; Etienne D Braekeleer; Chun-Wei Chen; Tajhal D Patel; Alejandra G Martell; Anna G Guzman; Katharina Wohlan; Sarah M Waldvogel; Hidetaka Uryu et al.
Source: check_circle
Crossref

SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells

eLife
2024-06-18 | Journal article
DOI: 10.7554/eLife.91611.3
Contributors: Linda Zhang; Joanne I Hsu; Etienne D Braekeleer; Chun-Wei Chen; Tajhal D Patel; Alejandra G Martell; Anna G Guzman; Katharina Wohlan; Sarah M Waldvogel; Hidetaka Uryu et al.
Source: check_circle
Crossref

Increased iron uptake by splenic hematopoietic stem cells promotes TET2-dependent erythroid regeneration

Nature Communications
2024-01-15 | Journal article
DOI: 10.1038/s41467-024-44718-0
Contributors: Yu-Jung Tseng; Yuki Kageyama; Rebecca L. Murdaugh; Ayumi Kitano; Jong Hwan Kim; Kevin A. Hoegenauer; Jonathan Tiessen; Mackenzie H. Smith; Hidetaka Uryu; Koichi Takahashi et al.
Source: check_circle
Crossref

Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity

2023-11-06 | Preprint
DOI: 10.21203/rs.3.rs-3516536/v1
Contributors: Ravi Majeti; Matthew Schwede; Katharina Jahn; Jack Kuipers; Linde Miles; Robert Bowman; Troy Robinson; Ken Furudate; Hidetaka Uryu; Tomoyuki Tanaka et al.
Source: check_circle
Crossref

A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies

Blood Cancer Discovery
2023-07-05 | Journal article
DOI: 10.1158/2643-3230.BCD-22-0205
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Data from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-07-05 | Preprint
DOI: 10.1158/2643-3230.c.6692454.v2
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Protocol from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-07-05 | Preprint
DOI: 10.1158/2643-3230.23627525
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Protocol from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-07-05 | Preprint
DOI: 10.1158/2643-3230.23627525.v1
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Tables and Figures from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-07-05 | Preprint
DOI: 10.1158/2643-3230.23627522.v1
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Tables and Figures from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-07-05 | Preprint
DOI: 10.1158/2643-3230.23627522
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Data from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-06-12 | Preprint
DOI: 10.1158/2643-3230.c.6692454.v1
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Protocol from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-06-12 | Preprint
DOI: 10.1158/2643-3230.23503818
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Protocol from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-06-12 | Preprint
DOI: 10.1158/2643-3230.23503818.v1
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Tables and Figures from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-06-12 | Preprint
DOI: 10.1158/2643-3230.23503815.v1
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

Supplementary Tables and Figures from A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in <i>IDH1</i>-Mutated Myeloid Malignancies

2023-06-12 | Preprint
DOI: 10.1158/2643-3230.23503815
Contributors: Curtis A. Lachowiez; Sanam Loghavi; Zhihong Zeng; Tomoyuki Tanaka; Yi June Kim; Hidetaka Uryu; Sven Turkalj; Niels Asger Jakobsen; Marlise R. Luskin; Dzifa Y. Duose et al.
Source: check_circle
Crossref

α-Mannan Can Induce Acute Pulmonary GvHD Dependent On Th17 Subsets

Biology of Blood and Marrow Transplantation
2013-02 | Journal article
DOI: 10.1016/j.bbmt.2012.11.085
Contributors: Hidetaka Uryu; Hideyo Oka; Sonoko Shimoji; Yoshihiro Eriguchi; Shuichiro Takashima; Koji Kato; Koichi Akashi; Takanori Teshima
Source: Self-asserted source
Hidetaka Uryu via Crossref Metadata Search

Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis

International Journal of Hematology
2007 | Journal article
DOI: 10.1007/bf02983996
Contributors: Mihoko Koseki; Noboru Asada; Hidetaka Uryu; Masami Takeuchi; Hidesaku Asakura; Kosei Matsue
Source: Self-asserted source
Hidetaka Uryu via Crossref Metadata Search

Rapid improvement of hypoxemia by the use of rituximab in patients with pulmonary intravascular lymphoma

Leukemia & Lymphoma
2007-01 | Journal article
DOI: 10.1080/10428190600909487
Contributors: Kosei Matsue; Masami Takeuchi; Hidetaka Uryu; Mihoko Koseki; Noboru Asada; Yosinori Kaneko
Source: Self-asserted source
Hidetaka Uryu via Crossref Metadata Search

Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia

Annals of Hematology
2006-03 | Journal article
DOI: 10.1007/s00277-005-0071-3
Contributors: Kosei Matsue; Masami Takeuchi; Mihoko Koseki; Hidetaka Uryu
Source: Self-asserted source
Hidetaka Uryu via Crossref Metadata Search
How many people are using ORCID?